CSIMarket
 
Davita Inc   (NYSE: DVA)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $180.9800 $-3.01 -1.636%
Day's High: $183.27499389648438 Week Perf: 2.75 %
Day's Low: $ 180.85 30 Day Perf: -1.52 %
Volume (M): 132,321 52 Wk High: $ 247.49
Volume (M$): $ 0 52 Wk Avg: $156.83
Open: $183.16 52 Wk Low: $101.00



 Market Capitalization (Millions $) 11,961
 Shares Outstanding (Millions) 66
 Employees 78,000
 Revenues (TTM) (Millions $) 14,010
 Net Income (TTM) (Millions $) 1,190
 Cash Flow (TTM) (Millions $) -71
 Capital Exp. (TTM) (Millions $) 583

Business Description


DaVita Inc. is a prominent provider of kidney care services, specializing in dialysis treatment for patients with chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates a vast network of outpatient dialysis centers across the United States, where it delivers both standard and specialized dialysis services to its patients.

In addition to its primary focus on dialysis services, DaVita also offers acute inpatient dialysis in approximately 700 hospitals, ensuring that patients receive necessary care during hospital stays. The companys operations are predominantly centered around dialysis and related services, which collectively contribute to about 97% of its total net revenues. The remaining 3% of revenues come from ancillary services and strategic initiatives that further support its core mission of renal care.

DaVita aims to enhance the quality of life for individuals with kidney disease through a comprehensive approach that includes timely care, education, and support for patients and their families. The company strives to improve health outcomes through innovative practices and patient-centric services, establishing itself as a leader in the kidney care sector.


   Company Address: 2000 16th Street Denver, 80202 CO
   Company Phone Number: 631-2100   Stock Exchange / Ticker: NYSE DVA


Customers Net Income grew by DVA's Customers Net Profit Margin grew to

66.65 %

4.75 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARDT   -0.09%    
CYH   -2.74%    
EHC        0.78% 
SGRY        0.5% 
THC   -1.02%    
UHS        0.31% 
• View Complete Report
   



Stocks on the Move

DaVita Inc. Continues to Outperform Market Despite FTC Investigation into Noncompete Agreements

Published Tue, Jul 16 2024 5:49 AM UTC

In recent news, DaVita Inc., one of the largest dialysis care providers in the United States, has caught the attention of the Federal Trade Commission (FTC). The FTC has launched an investigation into DaVita Inc. and Fresenius Medical Care AG, the two dominant players in the U.S. dialysis market, over allegations of noncompete agreements that make it difficult for physicians...

Stocks on the Move

Davita Incs Shares Experience Sell-Off Amidst Broader Market Decline

Published Wed, Jul 3 2024 12:31 PM UTC

Davita Inc, a renowned provider of kidney dialysis care, has recently faced a sell-off of its shares with a 2.04% decline on Friday. This downward trend follows three consecutive days of losses for the company s stock. However, it is important to note that Davita s shares have still outperformed the market year to date. This article will delve deeper into the recent sell-off...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 11.04
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.85
Price to Sales (Expected) -
Price to Book -
PEG (TTM) 0.55

Financial Strength Current
Quick Ratio 0.25
Working Capital Ratio 1.45
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.16

Per Share Current
Earnings (TTM) 16.39 $
Revenues (TTM) 211.97 $
Cash Flow (TTM) -
Cash 11 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 179,611
Net Income per Employee (TTM) 15,250
Receivable Turnover Ratio (TTM) 5.79
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.79

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) 16.29 %
Net Margin (MRQ) 9.66 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 20.66 %

Management Effectiveness Current
Return On Assets (TTM) 6.75 %
Return On Investment (TTM) 7.24 %
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Davita Inc's Segments
Elimination of interrevenues    -0.7 % of total Revenue
Medicare and Medicare Advantage    49.05 % of total Revenue
Medicaid and Managed Medicaid    6.23 % of total Revenue
Other Government Payors    9.99 % of total Revenue
Commercial Payors    31.15 % of total Revenue
Other    0.99 % of total Revenue
U S Dialysis And Related Lab Services    85.53 % of total Revenue
U S Dialysis And Related Lab Services Elimination of interrevenues    -0.6 % of total Revenue
U S Dialysis And Related Lab Services Medicare and Medicare Advantage    49.05 % of total Revenue
U S Dialysis And Related Lab Services Medicaid and Managed Medicaid    6.23 % of total Revenue
U S Dialysis And Related Lab Services Other Government Payors    2.72 % of total Revenue
U S Dialysis And Related Lab Services Commercial Payors    27.94 % of total Revenue
U S Dialysis And Related Lab Services Other    0.18 % of total Revenue
Other Segment    14.47 % of total Revenue
Other Elimination of interrevenues    -0.1 % of total Revenue
Other Medicare and Medicare Advantage    3.18 % of total Revenue
Other Other Government Payors    7.27 % of total Revenue
Other Commercial Payors    3.21 % of total Revenue
Other Other    0.81 % of total Revenue
U S Dialysis And Related Lab Services with Intersegment    86.13 % of total Revenue
U S Dialysis And Related Lab Services with InterExternal Sources    85.34 % of total Revenue
U S Dialysis And Related Lab Services with InterIntersubEliminations    0.6 % of total Revenue
Other with Intersegment    14.57 % of total Revenue
Other with InterIntersubEliminations    0.1 % of total Revenue
InterElimination    -0.7 % of total Revenue
InterElimination U S Dialysis And Related Lab Services    -0.6 % of total Revenue
InterElimination Other Segment    -0.1 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.